Skip to content
Cartherics Logo Cartherics Logo
  • Our Company
    • About Us
    • Our Vision & Mission
    • Founders
    • Board Members & Key Executives
    • Scientific Consultants
    • Partners & Collaborations
    • Our Lab
  • Technology
    • Our Technology
  • Pipeline
    • Our Pipeline
    • Scientific Publications
    • Scientific & Company Presentations
  • Careers
    • Careers at Cartherics
    • Education Opportunities
  • Latest News
  • Investors
  • Contact Us

Latest News

Home » Latest News
Latest Newscarth_admin2026-06-02T11:12:27+10:00
  • Categories: General

    Cartherics recognised as Asia Pacific Emerging Leader in Allogeneic Cell Therapy

    Published On: July 1st, 2026

    Melbourne, Australia, 1 July 2026 –   Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s [...]

    Read More
  • Categories: General The Pipeline

    Cartherics strengthens global IP portfolio with Japanese patent grant

    Published On: June 10th, 2026

    Melbourne, Australia, 10 June 2026 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, [...]

    Read More
  • Categories: General The Pipeline

    CAR-NK cell therapies for solid tumours: Closing the gap between perception and reality

    Published On: May 14th, 2026

    By Drs Ian Nisbet & Walid Azar As published in Pharmaphorum - 14 May 2026 Immune cell therapies have transformed [...]

    Read More
  • Categories: General

    World Ovarian Cancer Day Q&A: Heather Hawkins on symptoms, survival and progress

    Published On: May 8th, 2026

    Today on World Ovarian Cancer Day, we pause to listen, reflect, and amplify the voices of those who have experienced [...]

    Read More
  • Categories: General The Pipeline

    Cartherics and Catalent Expand Commercial License Agreement

    Published On: April 10th, 2026

    April 9 (US ET), 2026 – Melbourne, Australia, and Tampa, FL – Cartherics Pty Ltd, a biotechnology company developing off‑the‑shelf [...]

    Read More
  • Categories: Conferences General Investor News

    Off-the-Shelf, On-the-Money: How a Melbourne Biotech is Expanding its Oncology Platform to Endometriosis

    Published On: April 8th, 2026

    By Wholesale Investor In the high-octane world of biotechnology, success is often measured by the narrowest of margins. But for [...]

    Read More
  • Categories: Conferences General Investor News

    Cartherics CEO Dr Ian Nisbet presents at the Emergence Investment Conference

    Published On: March 2nd, 2026

    Cartherics is pleased to share Dr Ian Nisbet’s presentation at the Emergence Investment Conference in Sydney, where he outlined the [...]

    Read More
  • Categories: Conferences General

    Prof. Alan Trounson to present lecture at KAUST on immune cell therapies for women’s health

    Published On: February 3rd, 2026

    Cartherics is pleased to announce that Professor Alan Trounson AO, Deputy Chair, will deliver an invited lecture at King Abdullah [...]

    Read More
  • Categories: Conferences General

    Cartherics to present at the ANZ Biologics Festival 2026

    Published On: February 2nd, 2026

    Cartherics is pleased to announce that Dr Madeline Cao, Head of Manufacturing Development and Dr Walid Azar, Chief Scientific Officer, [...]

    Read More
  • Categories: General The Pipeline

    Cartherics granted key patent in China for TAG-72 CAR gene-modified stem cells

    Published On: January 29th, 2026

    Melbourne, Australia, 29 January 2026 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune cell therapies focusing on high-impact women’s diseases, [...]

    Read More
  • Categories: General

    Message from the CEO

    Published On: December 16th, 2025

    With the end of the year fast approaching, it is timely to take a step back and reflect on the [...]

    Read More
  • Categories: Conferences General Investor News People & Careers

    Cartherics to participate in prominent biotech investor conferences during JPM Healthcare Week

    Published On: December 16th, 2025

      Dr Ian Nisbet, Chief Executive Officer, is attending both the RESI Investor Conference and BIO Partnering Dr Vera Evtimov, [...]

    Read More
  • Categories: General People & Careers

    Cartherics Team Offsite: Stronger Together

    Published On: December 10th, 2025

    The Cartherics team recently gathered at the RACV Club in Healesville for a dynamic and inspiring offsite event focused on [...]

    Read More
  • Categories: Conferences General People & Careers

    Cartherics to present at the ISSCR 2025 Boston International Symposium

    Published On: December 8th, 2025

    Cartherics’ Deputy Chair, Prof. Alan Trounson AO will be presenting at ISSCR 2025 on Friday 12th December, 2025 at 3.25pm [...]

    Read More
  • Categories: General Investor News

    Launch of Evinco Therapeutics: A pioneering biotech company advancing immune therapies for Alzheimer’s disease

    Published On: December 4th, 2025

    Evinco Therapeutics is an Australian start-up on a mission to transform the treatment of Alzheimer’s disease and other neuroinflammatory conditions [...]

    Read More
12Next
  • Our Company
  • Technology
  • Pipeline
  • Latest News
  • Investors

12 Ferntree Place
Notting Hill VIC 3168
AUSTRALIA

info@cartherics.com

+61 1300 973 415

About us

Cartherics’ mission is the development of novel, immune cell therapy products for the treatment of cancer and endometriosis.

Sign up to our newsletter

Stay informed about our latest news and developments

* indicates required


© Copyright 2022 – 2026| Cartherics Pty Ltd

Page load link

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Cartherics
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Analytics

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Go to Top